Cardiac panel labs are one of the most important tools for understanding your cardiovascular health. Yet most people walk away from their results feeling confused about what the numbers mean. Many simply check whether a result is flagged high or low. But “within range” is not the same as optimal for your personalized risk targets.

Some of the most common questions I help my clients navigate involve blood work. Which cardiac labs should you have checked? What do the results actually mean? Lab results contain a lot of information, and it can feel overwhelming to know what to do with your numbers.

Below, we will review some of blood tests that are best for preventing heart related complications and what they mean. The goal is to help you feel confident and become an active participant in your care.

Wondering whether your current labs are telling the whole story? My free training is the perfect place to start. The 3 Heart Labs You Should Be Asking For (But Most People Aren’t) walks you through why traditional labs can miss hidden cardiovascular risk, which three specific labs add critical context to your heart health, and how these markers connect to plaque development, insulin resistance, and long-term heart outcomes. 

For an even more comprehensive look, enroll in my self-paced Know Your Numbers: Heart Labs Explained. It’s a step-by-step course that teaches you which heart health labs are essential and why they matter. You’ll learn how to interpret your results and take informed, proactive steps toward prevention.

The Role of Lab Tests in Assessing Heart Health

After reviewing thousands of lab panels, I’ve seen how often routine testing overlooks important cardiovascular signals.

Many providers reduce cardiovascular risk to a single number like LDL cholesterol, but heart disease doesn’t develop from one isolated value. It develops within a broader physiological environment that includes inflammation, oxidative stress, metabolic health, endothelial function, and lipid metabolism.

When those dots aren’t connected, clinicians can easily miss early changes already developing beneath the surface.

Heart disease remains the number one cause of death worldwide. Many people who receive a heart disease diagnosis never experienced obvious warning signs. In many cases, the earliest clues appear quietly in bloodwork long before symptoms develop.

Understanding which markers to look at and how they fit together enables a more proactive approach to your heart health.

Why Standard Cardiac Labs Often Miss the Full Picture

I have a 35-year-old male client who came to me after having a heart attack and didn’t understand why. His cardiologist looked at his lipid panel and put him on a statin.

When we met, I encouraged further testing. Every single marker came back elevated, including hs-CRP, Lp(a), and homocysteine. That told us so much more of his heart health story than his standard lipid panel ever could. We started tackling these through a targeted, science-based, nutrient-sufficient, anti-inflammatory diet tailored to his specific needs, with the goal of optimizing each marker to truly reduce his risk of having another heart attack.

In six months, his hs-CRP went from 6.2 to 0.6 mg/dL (normal: under 1.0), homocysteine from 15 to 7 umol/L (normal: under 10), apoB from 93 to 62 mg/dL (optimal for him: <70mg/dL), and HbA1c from 5.7% to 5.3%.

His high Lp(a) and prior heart attack place him in a very high risk category. We adjusted his targets to be more aggressive than standard guidelines suggest, particularly around apoB.

Let’s take a closer look at these important cardiac panel labs. 

Cardiac Panel Blood Tests for Heart Health

A cardiac panel typically includes a combination of metabolic, inflammatory, and lipid markers. While there are many individual tests worth knowing, in this blog, I will focus on blood sugar and insulin resistance, lipid metabolism, and inflammation. 

For a deeper dive, my Know Your Numbers: Heart Labs Explained course goes further into oxidative stress, endothelial dysfunction, micronutrient deficiencies, and more. 

Blood Sugar & Insulin Resistance

A CMP measures fasting blood glucose, giving you a snapshot of your blood sugar at a single point in time. To get a fuller picture of insulin resistance and cardiovascular risk, discuss these additional markers with your healthcare provider:

• Hemoglobin A1c (HgA1c): Measures average blood sugar levels over the past 2-3 months, helping to detect prediabetes or diabetes. Normal: below 5.7%, Optimal: between 5 and 5.4%.
• HOMA-IR (Homeostatic Model Assessment of Insulin Resistance): A calculation derived from fasting glucose and insulin that reflects how efficiently the body regulates blood sugar. While useful, it primarily captures hepatic insulin resistance in the fasting state and can appear normal even when other markers already signal early metabolic dysfunction, making it a helpful but not always sensitive early indicator of cardiometabolic risk. Optimal: below 1.0.
• LP-IR (Lipoprotein Insulin Resistance): Often the earliest and most comprehensive marker of insulin resistance on a cardiac panel, LP-IR detects changes in lipoprotein particles before glucose or insulin levels look abnormal. As insulin resistance develops, the liver produces more triglyceride-rich VLDL particles, HDL decreases, and LDL shifts toward smaller, denser particles, all of which increase cardiovascular risk. LP-IR combines six lipoprotein measures into a single score from 0 to 100 to help predict future diabetes and premature cardiovascular disease. Optimal: below 30. Scores below 45 indicate low risk.
• TG/HDL Ratio (Triglyceride to HDL Ratio): A practical cardiac lab value that can be pulled directly from a standard lipid panel and used as an accessible screening tool for insulin resistance. When insulin resistance is present, triglycerides tend to rise and HDL tends to fall, and a higher ratio signals increased cardiovascular risk. It’s not as detailed as LP-IR and can be affected by short-term factors like diet or stress, but it’s a useful and widely available starting point. Note that its accuracy varies across ethnic groups. Optimal: below 2.0.

It’s worth noting that insulin resistance and diabetes aren’t the same thing. Insulin resistance is an earlier, often silent stage where your cells stop responding efficiently to insulin, and it can begin a decade or more before blood sugar levels even start to rise. 

This matters because insulin resistance itself, even before it progresses to diabetes, can raise remnant cholesterol and drive inflammation in the artery walls, both of which contribute to plaque formation and increased heart disease risk. Catching it early gives you the opportunity to intervene with targeted, science-based nutrition and lifestyle changes before the condition advances.

Inflammation and Heart Disease

Research shows that inflammation within the walls of your arteries can accelerate plaque formation. Even if you have a normal LDL but high inflammation, your cardiovascular risk still increases.

Inflammatory markers are a critical, and often overlooked, component of a complete cardiac panel labs. Here, I highlight two key inflammatory markers worth knowing. For a more complete breakdown, including additional markers we track in practice, check out my Know Your Numbers: Heart Labs Explained course.

• High-Sensitivity C-Reactive Protein: CRP is a protein produced by your liver in response to stress, infection, or inflammation. The high-sensitivity version, hs-CRP, is specifically designed to detect the low-grade, chronic inflammation that standard CRP can miss, making it the preferred marker for cardiovascular risk assessment. Elevated hs-CRP levels have been linked to artery wall inflammation and a higher risk of atherosclerosis. 
  • What’s optimal? hs-CRP levels below 1.0 mg/L indicate low inflammation, while levels above 3.0 mg/L suggest a higher risk for cardiovascular disease. 
  • hs-CRP is a nonspecific marker and is more sensitive to detecting low-grade inflammation. CRP, on the other hand, can be influenced by recent infections. Both should be evaluated alongside other heart health indicators for a more comprehensive picture.
• Lp-PLA2 (Lipoprotein-associated phospholipase A2): Lp-PLA2 is an enzyme that appears to promote inflammation and plaque formation in your artery walls. Research suggests that having high CRP and Lp-PLA2 levels can increase your risk of ischemic stroke. The target value for Lp-PLA2 is <123 nmol/min/mL.

Standard Lipid Profile

A lipid profile with the tests below can help determine your risk of heart and blood vessel disease.

• Total Cholesterol: Your total cholesterol is the sum of all of the parts of your blood cholesterol (your LDL, HDL, and other lipid components, such as some of your triglycerides). Elevated total cholesterol may indicate a higher risk of heart disease. Optimal: below 200 mg/dL, though for those at high cardiovascular risk, a target below 150 mg/dL may be more appropriate based on your individual risk factors and healthcare provider’s guidance.
• LDL Cholesterol: LDL is typically the most abundant atherogenic lipoprotein in circulation and the most commonly used marker for assessing plaque risk in the arteries. While useful, it is a calculated estimate and doesn’t capture the full picture of atherogenic burden. ApoB, which directly counts every particle that contributes to plaque formation, is considered a more precise marker of cardiovascular risk. This can lead to blockages which increase your risk for a heart attack or stroke. Optimal: below 100 mg/dL, or below 70 mg/dL for those with existing heart disease or elevated Lp(a).
• HDL Cholesterol: Your HDL cholesterol helps reduce circulating atherogenic cholesterol in your blood. This lowers the amount available to contribute to plaque formation in your arteries.
  • We used to think just having high HDL would protect us against developing high LDL. However, we now know that LDL is an independent risk factor for heart disease, and having high levels can actually make it dysfunctional, especially in postmenopausal women. Optimal: 60-80 mg/dL.
• Non-HDL Cholesterol: Calculated by subtracting your HDL from your total cholesterol, non-HDL-C captures all atherogenic particles in your blood, including LDL, IDL, and VLDL, making it a more complete picture of plaque-forming risk than LDL alone. While apoB is the most precise marker of atherogenic burden since it directly counts every particle that contributes to plaque formation, non-HDL-C is the best available alternative if apoB testing is not accessible. Optimal: below 130 mg/dL.
• Triglycerides: Triglycerides are a type of fat in your blood. High triglyceride levels can contribute to atherosclerosis, blood clotting, stroke risk, and heart disease risk, as they cause the narrowing of your arteries. Optimal: below 100 mg/dL.

A lipid profile is just one piece of the puzzle. Assessing your full cardiovascular risk also includes age, family history, medical history, gut health, and lifestyle. Together, these inform a personalized nutrition and lifestyle plan that supports your heart health goals.

Key Advanced Lipid Panel Markers

Advanced lipid markers aren’t always included in routine testing, but asking for them can significantly improve your understanding of true cardiovascular risk. These tests are especially valuable for people with diabetes, insulin resistance, or existing heart disease, but they’re an important tool for everyone, regardless of family history, to optimize their heart health early.

If you want step-by-step guidance on how to read and interpret each of these markers, my Know Your Numbers: Heart Labs Explained course walks you through each test in plain language — so you can have informed conversations with your healthcare provider and advocate for the right testing.

• Lipoprotein(a): Lp(a) is a genetic marker that signifies an increased susceptibility to arterial plaque buildup, cardiovascular events, heart failure, and aortic stenosis. So, having an awareness of this marker can help guide your risk management plan, often shifting target levels for other cardiovascular markers, like LDL cholesterol, to more aggressive thresholds than for the general population. Did you know I have high Lp(a)? 
• Apolipoprotein B: Apolipoprotein B is a direct marker of atherogenic cholesterol, attaching to every particle that contributes to plaque buildup, including LDL, VLDL, IDL, and Lp(a). High levels of ApoB may indicate that you’re at higher risk for plaque formation and developing heart disease. Research suggests that testing ApoB may be a better overall marker of heart disease risk than LDL alone.
• LDL Particle Number and Size: Beyond a standard LDL value, the number and size of your LDL particles provide important additional insight into your cardiovascular risk. In my Know Your Numbers: Heart Labs Explained course, I do a deep dive into NMR fractionation, including LDL particle number and size, and what your results mean for your heart health.

Therefore, looking beyond a simple LDL value can provide important insight into your risk.

Cardiac Panel Labs for Heart Attack & Stress Detection

A damaged or stressed heart releases specific biomarkers into the blood. These markers can help doctors assess whether a person has experienced a heart attack or cardiac injury, guiding the next steps.

Some common cardiac markers include:

• Troponin: This is the most sensitive and specific marker for heart muscle damage, making it the gold standard for diagnosing heart attacks. When heart cells are injured, troponin levels rise within hours and can remain elevated for up to two weeks, providing a clear indicator of cardiac stress.
• Creatine Kinase (CK): CK is an enzyme found in the heart, muscles, and brain, and its levels increase when there is muscle damage, including damage to the heart. While CK can indicate cardiac injury, it’s less specific than troponin, as it can also increase from muscle inflammation, trauma, or intense exercise. High CK is also associated with high blood pressure and bleeding risk.
• Myoglobin: Myoglobin is a small protein that helps move oxygen in your muscle cells. Interestingly, it’s also one of the first markers to rise following a heart attack. However, because myoglobin is found in all muscles, non-cardiac conditions like muscle injuries can also elevate levels, making it a less specific indicator of heart damage.

Your Cardiac Panel Labs: Next Steps

According to the American Heart Association, a whopping 80% of cardiovascular diseases (including heart disease and stroke) are preventable. Being an active participant in your health means understanding your blood tests for heart health and taking action through science-based nutrition and lifestyle management.

Knowing your numbers is the first step, but what you do with them is what truly matters. The goal isn’t just awareness, it’s optimizing each marker through targeted, science-based nutrition to meaningfully reduce your cardiovascular risk.

Heart disease is often silent, but your labs aren’t. The problem is that most people are told their results are “fine” or “within range,” which usually just means it’s not high enough for their doctor to prescribe medication. That’s not the same as optimal.

That’s exactly why I created Know Your Numbers: Heart Labs Explained, a self-paced course that gives you clinical-level clarity on your cardiac panel labs without needing a medical degree.

Inside the course, you’ll learn:

• Which cardiac labs truly matter for cardiovascular health, including ones your doctor often skips but that are critical for early intervention
• How to view and interpret your results with confidence, so you can have informed conversations with your healthcare provider
• What your numbers could be telling you about inflammation, plaque risk, and overall heart function
• How to use a fillable lab tracking sheet to spot trends over time and catch early changes before they become bigger issues

This course is for anyone who has ever walked out of a doctor’s office feeling confused about their cardiac labs and wants real clarity, not just a report marked “within range.” You don’t need a background in medicine. You just need the right information, explained simply.

Note: This course focuses on understanding your cardiac panel results. If you’re looking for personalized strategies to improve your numbers, that’s what we cover in my 6-week Optimize group coaching program.

Ready to take control? Access the course here.

About the Author 

Michelle Routhenstein, MS, RD, CDE is a Cardiology Dietitian and Preventive Cardiology Nutritionist with over 14 years of experience helping people take control of their heart health. She graduated cum laude from New York University with both a Bachelor of Science and Master of Science in Nutrition and Dietetics, and has worked in clinical settings including a level-one trauma hospital in NYC.

As the owner of Entirely Nourished, Michelle has helped thousands of individuals lower their blood pressure and cholesterol, reduce their risk of heart attacks and strokes, and in many cases reduce or eliminate heart medications entirely through her science-based, personalized approach to nutrition. 

Cardiac Panel Labs FAQs

Does cardiac panel need fasting? 

Some components of a cardiac panel do require fasting for accurate results, particularly triglycerides and fasting glucose. Generally, a 9 to 12 hour fast is recommended before your blood draw. However, not all tests require fasting, so I always recommend confirming with your healthcare provider ahead of your appointment to ensure your results are as accurate as possible.

What is included in a cardiac panel? 

A standard cardiac panel typically includes a lipid profile (total cholesterol, LDL, HDL, triglycerides), a comprehensive metabolic panel (CMP), and inflammatory markers such as hs-CRP. An advanced cardiac panel may also include Lp(a), ApoB, and LDL particle number and sizes. I always recommend asking your healthcare provider for the full panel, not just the basics, to get a true picture of your cardiovascular health.

Can a CMP detect heart problems? 

A comprehensive metabolic panel (CMP) can provide important clues about heart health, including blood sugar levels, kidney function, and electrolyte balance, all of which are connected to cardiovascular risk. However, a CMP alone is not sufficient to fully assess heart disease risk. It should be evaluated alongside a full cardiac panel and other clinical markers for a complete picture.

How do they test for heart conditions? 

Heart conditions are assessed through a combination of blood tests, clinical evaluations, and imaging. From a lab perspective, a comprehensive cardiac panel is one of the primary tools used to evaluate cardiovascular risk, measuring cholesterol, inflammation, blood sugar, and cardiac enzymes. Your healthcare provider may also order an EKG, echocardiogram, stress test, coronary calcium score, carotid ultrasound, or CIMT (carotid intima-media thickness) depending on your symptoms and risk factors. Understanding your cardiac labs is a critical first step in this process. 

References

1. Dal Canto E, et al. Diabetes as a cardiovascular risk factor. Eur J Prev Cardiol. 2019. https://pubmed.ncbi.nlm.nih.gov/31722562/
2. Sachdeva A, et al. Lipid levels in patients hospitalized with coronary artery disease. Am Heart J. 2009. https://pubmed.ncbi.nlm.nih.gov/19081406/
3. Ballantyne CM, et al. Lp-PLA2, hs-CRP, and risk for incident ischemic stroke. Arch Intern Med. 2005. https://pubmed.ncbi.nlm.nih.gov/16314544/
4. Jung E, et al. Serum Cholesterol Levels and Risk of Cardiovascular Death. Int J Environ Res Public Health. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9316578/
5. Trimarco V, et al. High HDL Cholesterol Increases Cardiovascular Risk in Hypertensive Patients. Hypertension. 2022. https://pubmed.ncbi.nlm.nih.gov/35968698/
6. Kathariya G, et al. Is evaluation of non-HDL-C better than calculated LDL-C? Indian Heart J. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7411097/
7. Behbodikhah J, et al. Apolipoprotein B and Cardiovascular Disease. Metabolites. 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8540246/
8. Shapiro MD, Fazio S. Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease. F1000Res. 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5310383/
9. Hoff J, et al. Troponin in Cardiovascular Disease Prevention. Curr Atheroscler Rep. 2016. https://pubmed.ncbi.nlm.nih.gov/26879078/
10. Aydin S, et al. Biomarkers in acute myocardial infarction. Vasc Health Risk Manag. 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC6340361/
11. American Heart Association. CDC Prevention Programs. 2023. https://www.heart.org/en/get-involved/advocate/federal-priorities/cdc-prevention-programs